期刊论文详细信息
Journal of Bone Oncology
Efficacy and safety of denosumab versus zoledronic acid in delaying skeletal-related events in patients with gastrointestinal cancer, pancreas-biliary system cancer, and other rare cancers
Shin Takahashi1  Chikashi Ishioka1  Masanobu Takahashi1  Hideharu Yamada1  Hideki Shimodaira1  Kota Ohuchi2  Masahiro Takahashi2  Yoshinari Okada2  Hiroo Imai2  Ken Saijo2  Keigo Komine2 
[1] Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University, 4-1, Seiryo-machi, Aobaku, Sendai 980-8575, Japan;Department of Medical Oncology, Tohoku University Hospital, 1-1, Seiryo-machi, Aobaku, Sendai 980-8547, Japan;
关键词: Denosumab;    Zoledronic acid;    Bone metastases;    Gastrointestinal cancer;    Pancreas-biliary system cancer;    Rare cancers;   
DOI  :  10.1016/j.jbo.2016.10.002
来源: DOAJ
【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:1次